Cyclic GMP and PKG signaling in heart failure

G Numata, E Takimoto - Frontiers in pharmacology, 2022 - frontiersin.org
Cyclic guanosine monophosphate (cGMP), produced by guanylate cyclase (GC), activates
protein kinase G (PKG) and regulates cardiac remodeling. cGMP/PKG signal is activated by …

Phosphodiesterases: Evolving Concepts and Implications for Human Therapeutics

ED Kelly, MJ Ranek, M Zhang, DA Kass… - Annual Review of …, 2025 - annualreviews.org
Phosphodiesterases (PDEs) are a superfamily of enzymes that hydrolyze cyclic nucleotides.
While the 11 PDE subfamilies share common features, key differences confer signaling …

Activation of ULK1 to trigger FUNDC1-mediated mitophagy in heart failure: effect of Ginsenoside Rg3 intervention

X Wang, G Ling, Y Wei, W Li, Y Zhang, N Tan, W Li… - Phytomedicine, 2023 - Elsevier
Background Although the development of therapies for heart failure (HF) continues apace,
clinical outcomes are often far from ideal. Unc51-like-kinase 1 (ULK1)-mediated mitophagy …

Regulation of mTOR signaling: Emerging role of cyclic nucleotide-dependent protein kinases and implications for cardiometabolic disease

F Shi, S Collins - International Journal of Molecular Sciences, 2023 - mdpi.com
The mechanistic target of rapamycin (mTOR) kinase is a central regulator of cell growth and
metabolism. It is the catalytic subunit of two distinct large protein complexes, mTOR complex …

The importance of mTORC1-autophagy axis for skeletal muscle diseases

X Han, KY Goh, WX Lee, SM Choy… - International Journal of …, 2022 - mdpi.com
The mechanistic target of rapamycin (mTOR) complex 1, mTORC1, integrates nutrient and
growth factor signals with cellular responses and plays critical roles in regulating cell growth …

The complex network of mTOR signalling in the heart

S Sciarretta, M Forte, G Frati… - Cardiovascular …, 2022 - academic.oup.com
The mechanistic target of rapamycin (mTOR) integrates several intracellular and
extracellular signals involved in the regulation of anabolic and catabolic processes. mTOR …

MTORC1-regulated metabolism controlled by TSC2 limits cardiac reperfusion injury

CU Oeing, S Jun, S Mishra, BL Dunkerly-Eyring… - Circulation …, 2021 - Am Heart Assoc
Rationale: The mTORC1 (mechanistic target of rapamycin complex-1) controls metabolism
and protein homeostasis and is activated following ischemia reperfusion (IR) injury and by …

Rheostatic balance of circadian rhythm and autophagy in metabolism and disease

X Wang, Z Xu, Y Cai, S Zeng, B Peng, X Ren… - Frontiers in Cell and …, 2020 - frontiersin.org
Circadian rhythms are physical, behavioral and environmental cycles that respond primarily
to light and dark, with a period of time of approximately 24 h. The most essential …

Indirect epigenetic testing identifies a diagnostic signature of cardiomyocyte DNA methylation in heart failure

CU Oeing, ME Pepin, KB Saul, AS Agircan… - Basic Research in …, 2023 - Springer
Precision-based molecular phenotyping of heart failure must overcome limited access to
cardiac tissue. Although epigenetic alterations have been found to underlie pathological …

Metformin-enhanced cardiac AMP-activated protein kinase/Atrogin-1 pathways inhibit charged multivesicular body protein 2b accumulation in ischemia–reperfusion …

T Li, Y Yin, N Mu, Y Wang, M Liu, M Chen… - Frontiers in Cell and …, 2021 - frontiersin.org
Background: Cardiac autophagic flux is impaired during myocardial ischemia/reperfusion
(MI/R). Impaired autophagic flux may exacerbate MI/R injury. Charged multivesicular body …